In response to this induced antitumor immunity, tumors evade the host immune response by expressing immune-exhausting molecules, such as PD-1, PD-L1, and CTLA-4, on the surface of tumor cells or tumor-infiltrating cells in the TIME, and they grow and develop [24,25,26,27,28]. The gene discussed is CTLA4; the disease is neoplasm.